Premium
Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5,00k | 873,97k | Derivative Exercise and Sale | 52,27 - 230,41 | 41,38k | - |
| 2026-05-01 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 108,25k | Automatic Disposition | 227,37 - 234,09 | 40,58k | -1,14% |
| 2026-05-12 | Dr. John Warren KozarichIndependent Chairman | -2,03k | 313,45k | Derivative Exercise and Sale | 69,51 - 224,00 | 40,58k | - |
| 2026-05-01 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5,00k | 895,21k | Derivative Exercise and Sale | 52,27 - 234,02 | 41,38k | - |
| 2026-04-01 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 94,44k | Automatic Disposition | 199,97 - 204,26 | 41,04k | -1,13% |
| 2026-04-01 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5,00k | 744,87k | Derivative Exercise and Sale | 52,27 - 204,50 | 41,38k | - |
| 2026-03-06 | Dr. John L. LaMattinaIndependent Director | -2,16k | 187,16k | Derivative Exercise and Sale | 114,15 - 200,76 | 29,52k | - |
| 2026-03-23 | Dr. Stephen Lawrence SabbaIndependent Director | -1 000,00 | 207,87k | Vente | 207,87 | 31,58k | -3,07% |
| 2026-03-11 | Mr. Octavio EspinozaCFO | -2,41k | 318,30k | Derivative Exercise and Sale | 92,65 - 225,00 | 21,01k | - |
| 2026-03-11 | Mr. Octavio EspinozaCFO | -652,00 | 146,70k | Automatic Disposition | 225,00 | 21,01k | -3,01% |
| 2026-03-04 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5,00k | 770,42k | Derivative Exercise and Sale | 52,27 - 208,87 | 36,87k | - |
| 2026-03-04 | Mr. Octavio EspinozaCFO | -2,07k | 283,93k | Derivative Exercise and Sale | 58,49 - 201,73 | 21,66k | - |
| 2026-03-04 | Mr. Octavio EspinozaCFO | -11,35k | 2,35M | Automatic Disposition | 201,73 - 208,80 | 21,66k | -34,38% |
| 2026-03-03 | Dr. Stephen Lawrence SabbaIndependent Director | -2,03k | 268,47k | Derivative Exercise and Sale | 69,51 - 201,50 | 32,58k | - |
| 2026-03-02 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 93,63k | Automatic Disposition | 197,14 - 203,57 | 41,51k | -1,11% |
| 2026-02-14 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -9,68k | 1,78M | Sale to Issuer | 183,83 | 36,87k | -20,80% |
| 2026-02-14 | Mr. Octavio EspinozaCFO | -11,76k | 2,16M | Sale to Issuer | 183,83 | 33,01k | -26,27% |
| 2026-02-14 | Mr. Todd C. DavisCEO & Director | -32,88k | 6,04M | Sale to Issuer | 183,83 | 163,82k | -16,71% |
| 2026-02-02 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 91,49k | Automatic Disposition | 191,00 - 197,20 | 41,98k | -1,10% |
| 2026-01-02 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 88,53k | Automatic Disposition | 186,59 - 192,40 | 42,45k | -1,09% |
| 2025-12-16 | Mr. Octavio EspinozaCFO | 2,38k | 164,30k | Derivative Exercise and Retained Stock | 52,84 - 103,42 | 28,57k | 9,09% |
| 2025-12-12 | Mr. Octavio EspinozaCFO | -1,80k | 339,71k | Vente | 188,31 | 26,19k | -6,45% |
| 2025-12-05 | Mr. Octavio EspinozaCFO | -1,86k | 344,23k | Sale to Issuer | 184,87 | 27,99k | -6,24% |
| 2025-12-04 | Mr. Todd C. DavisCEO & Director | -130,00 | 0,00 | Other Disposition | - | 112,66k | -0,12% |
| 2025-12-08 | Mr. Jason M. AryehIndependent Director | 2,03k | 141,38k | Derivative Exercise and Retained Stock | 69,51 | 75,14k | 2,78% |
| 2025-12-01 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 91,46k | Automatic Disposition | 193,86 - 200,02 | 42,91k | -1,08% |
| 2025-11-07 | Dr. John L. LaMattinaIndependent Director | -4,18k | 575,34k | Derivative Exercise and Sale | 66,13 - 205,45 | 29,52k | - |
| 2025-11-07 | Dr. Nancy Ryan GrayIndependent Director | -6,57k | 892,83k | Derivative Exercise and Sale | 66,19 - 205,45 | 6,89k | - |
| 2025-11-03 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 89,22k | Automatic Disposition | 189,00 - 192,38 | 43,38k | -1,07% |
| 2025-10-01 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 83,80k | Automatic Disposition | 177,60 - 181,18 | 43,85k | -1,05% |
| 2025-09-22 | Dr. Martine ZimmermannIndependent Director | -115,00 | 19,64k | Sale to Issuer | 170,77 | - | - |
| 2025-09-23 | Mr. Jason M. AryehIndependent Director | -10,00k | 1,71M | Vente | 170,41 - 171,92 | 73,11k | -12,03% |
| 2025-09-02 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 75,77k | Automatic Disposition | 161,51 - 164,25 | 44,31k | -1,04% |
| 2025-08-10 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -1,33k | 198,83k | Sale to Issuer | 150,06 | 30,81k | -4,12% |
| 2025-08-01 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 61,59k | Automatic Disposition | 131,88 | 44,78k | -1,03% |
| 2025-07-10 | Dr. John Warren KozarichIndependent Chairman | -934,00 | 116,75k | Automatic Disposition | 125,00 | 45,25k | -2,02% |
| 2025-06-23 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -500,00 | 57,04k | Vente | 114,08 | 31,90k | -1,54% |
| 2025-06-10 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -500,00 | 57,27k | Vente | 114,54 | 32,40k | -1,52% |
| 2025-06-06 | Dr. Martine ZimmermannIndependent Director | -188,00 | 19,93k | Sale to Issuer | 105,99 | - | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
